Latest Regulatory Progress News

Imugene Limited has received positive feedback from the FDA, aligning key requirements to progress its azer-cel therapy into a pivotal clinical trial, underscoring its growing promise in blood cancer treatment.

Chalice Mining’s Pre-Feasibility Study confirms the Gonneville Project as a long-life, low-cost critical minerals mine in Western Australia, projecting A$4.7 billion pre-tax free cashflow over 23 years with rapid payback.

Island Pharmaceuticals has been granted a pivotal US patent extending protection for its antiviral drug Galidesivir as a Covid-19 treatment until 2042, reinforcing its strategic position in the antiviral market.

Emerald Resources has secured mining approval for its Dingo Range Gold Project in Western Australia and completed a major accommodation camp, marking significant progress toward its goal of becoming a multi-mine gold producer.

Jameson Resources has locked in a $3 million capital raise from strategic investor King George Investments to advance its Crown Mountain coal project in British Columbia. The placement, priced at a 16.7% discount, underscores growing confidence in the project’s regulatory progress and market potential.

Viridis Mining and Minerals advances its Colossus Rare Earth Project with a favorable environmental assessment, despite a temporary regulatory pause to address public prosecutor concerns.

Uscom Limited reported a 25% revenue decline in FY25 amid global geopolitical challenges but reinforced its commitment to growth through strategic partnerships and innovative medical technologies.

Anteris Technologies Global Corp. has filed a Form S-1 registration statement with the SEC to enable resale of shares issued in a recent private placement, marking a key step in advancing its DurAVR transcatheter heart valve system and pivotal clinical trials.

Right Resources has confirmed extensive high-grade gold mineralisation along a 1km strike at its Pilot Project in New South Wales, with maiden drilling now in progress to validate these promising findings.

Island Pharmaceuticals has secured membership in the Medical Countermeasures Coalition, positioning its antiviral Galidesivir for critical US government stockpiling and regulatory milestones.

The a2 Milk Company has secured key regulatory approvals in China, moving closer to launching its infant formula products under the a2MC brand by mid-2027.

Lake Resources N.L. reports significant progress on its Kachi lithium project, unveiling enhanced project economics and next-generation lithium extraction technology amid a bullish lithium market and supportive Argentine political climate.